Assessing product health impacts
Philip Morris International’s smoke-free products are assessed for their harm reduction potential by the Chief Medical Officer’s team.
Harm reduction is nothing new—but assessment is vital to understand the impact when applied to tobacco
That's why our Chief Medical Officer team—led by Dr. Patrick Picavet—conducts rigorous assessments of clinical and real-world data to demonstrate the totality of evidence supporting the individual and public health benefits of our smoke-free products.
Assessing the health impacts of our products
The team led by Philip Morris International’s Chief Medical Officer assesses the harm reduction potential of our better alternatives to smoking in controlled clinical studies and in the real world.
“It would be one of the biggest public health impacts that has ever happened”
Dr. Patrick Picavet and his team explain how their vital research on the health impacts of switching from cigarettes to smoke-free products helps assess the potential impact on individuals and society.
